Multivalent interactions between streptavidin-based pretargeting fusion proteins and cell receptors impede efficient internalization of biotinylated nanoparticles
- 1 November 2017
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 63, 181-189
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticlesScientific Reports, 2016
- Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug deliveryJournal of Controlled Release, 2015
- Magnetic nanoparticle-based drug delivery for cancer therapyBiochemical and Biophysical Research Communications, 2015
- Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor AccumulationNano Letters, 2015
- Design Strategies and Applications of Circulating Cell-Mediated Drug Delivery SystemsACS Biomaterials Science & Engineering, 2015
- Ultrasonically triggered drug delivery: Breaking the barrierColloids and Surfaces B: Biointerfaces, 2014
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biologyAdvanced Drug Delivery Reviews, 2014
- Magnetic nanoparticle drug delivery systems for targeting tumorApplied Nanoscience, 2013
- Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging CapabilitiesScience, 2012
- Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example2009